ARCHIVES

Cancer Groups Urge FDA To Spell Out Standards For Data Collection In Time-To-Progression Trials.

This article is from The Cancer Letter archive.

Vol. 34 No. 41 | November 7, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Raises New Questions About Duke Genomics Research, Cuts Assay From Trial

May 14, 2010

In Brief: Leukemia Society, Glaxo Award Fellowship; Penn Leads CLF; Wight Heads Charity

September 10, 1999

Unique Molecular Profile For Lung Cancer Described

March 31, 2006

Tobacco Linked To 63 Percent Of Cancer Deaths In Black Men

July 29, 2005

NY Attorney General Sues Drug Companies Over Cancer Drug Pricing Deals

February 14, 2003

ASCO to Present 2013 Special Awards at Annual Meeting

May 31, 2013